ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1448

Utility of Digital Signals and Patient Reported Data Gathered in a Decentralized Study to Predict SLE Patient-Reported Flares

Eldon Jupe1, Gerald Lushington2, Mohan Purushothaman1, Fabricio Pautasso1, Georg Armstrong1, Arif Sorathia1, Jessica Crawley1, Vijay Nadipelli3, Bernie Rubin4, Ryan Newhardt1, Melissa Munroe1 and Brett Adelman1, 1Progentec Diagnostics, Inc., Oklahoma City, OK, 2Progentec Diagnostics, Inc., Oklahoma City, OR, 3GlaxoSmithKline, Philadelphia, PA, 4GlaxoSmithKline, US Medical Affairs and Immuno-inflammation, Durham, NC

Meeting: ACR Convergence 2022

Keywords: Disease Activity, Patient reported outcomes, physical activity, quality of life, Systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 13, 2022

Title: SLE – Diagnosis, Manifestations, and Outcomes Poster II: Manifestations

Session Type: Poster Session C

Session Time: 1:00PM-3:00PM

Background/Purpose: Systemic lupus erythematosus (SLE) is a heterogeneous autoimmune disease characterized by varied immune dysregulation. SLE patients often experience episodic flares, leading to organ damage and poor quality of life. A fully decentralized Mobile Study to Measure and Predict Lupus Disease Activity Using Digital Signals (OASIS) was conducted to explore the utility of digital signals and patient reported data in predicting impending SLE patient-reported flares.

Methods: We recruited study participants from Progentec’s LupusCorner community of ~120,000 patients, using digital marketing linked to online eligibility screening procedures. Adult, non-pregnant, patients with a self-reported diagnosis of SLE were appropriately consented and provided a mobile application (security/privacy protocol compliant) to record patient profile (PP) information (demographics, symptoms, and medication use) and quality of life (QOL) metrics, including the SLEQOL instrument. Patients who agreed to fully participate in the six-month study were provided a smartwatch to record physical activity (PA) parameters, heart rate, and sleep duration/depth. PP, QOL, and PA data were examined in aggregate via linear regression for their capacity to predict emergent patient reported SLE ‘flare’ scores. The resulting model was derived from feature selection using the ClassifierAttributeEval method (E. Frank et al. The WEKA Workbench. Morgan Kaufmann. 2016) and validated using 5-fold cross-validation.

Results: A total of 532 participants (self-reported SLE patients) consented and actively participated in the study; the majority were female and of European American descent, with an average age of 44 years (Table 1). Most participants (88%) reported being treated by a rheumatologist. A total of 144 participants (27%) consented to wearing the smartwatch device. These data, in conjunction with PP and QOL data, were used to derive a 94-feature regression model (Fig. 1) whose correlation coefficient (R2 = 0.75 ± 0.13; 95% CI) implies a significant but approximate (mean relative error = 63.2%) capacity to predict emergent self-reported SLE ‘flare’ scores. Descriptors with the high feature selection loadings included quantified PA values for moderate and intense patient physical activity, plus self-reported QOL, physical discomfort including epidermal, joint, oral pain, and other concerns serious enough to require medical attention in days prior to self-reported flare. Time-invariant PP terms generally exhibited low self-reported flare sensitivity, but several PP terms (relating to patient responsibilities, such as childcare) had substantial loadings, which implies that demographic profiles influence which time-variant metrics most affect ‘flare’ activity for different patient subgroups.

Conclusion: Regular profiling of patient self-reported well-being and biometric activity may offer promising screening potential to identify patients warranting further clinical assessment. Our study findings indicate the need to integrate additional data from medical records to further refine and validate these predictive models.

Supporting image 1

Supporting image 2


Disclosures: E. Jupe, Progentec Diagnostics, Inc.; G. Lushington, Progentec Diagnostics, Inc.; M. Purushothaman, Progentec Diagnostics, Inc.; F. Pautasso, Progentec Diagnostics, Inc.; G. Armstrong, Progentec Diagnostics, Inc.; A. Sorathia, Progentec Diagnostics, Inc.; J. Crawley, Progentec Diagnostics, Inc.; V. Nadipelli, GlaxoSmithKlein(GSK); B. Rubin, GlaxoSmithKline (GSK); R. Newhardt, None; M. Munroe, Progentec Diagnostics, Inc.; B. Adelman, Progentec Diagnostics, Inc..

To cite this abstract in AMA style:

Jupe E, Lushington G, Purushothaman M, Pautasso F, Armstrong G, Sorathia A, Crawley J, Nadipelli V, Rubin B, Newhardt R, Munroe M, Adelman B. Utility of Digital Signals and Patient Reported Data Gathered in a Decentralized Study to Predict SLE Patient-Reported Flares [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/utility-of-digital-signals-and-patient-reported-data-gathered-in-a-decentralized-study-to-predict-sle-patient-reported-flares/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/utility-of-digital-signals-and-patient-reported-data-gathered-in-a-decentralized-study-to-predict-sle-patient-reported-flares/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology